Will Next Generation Obesity Drugs make Bariatric Surgery Obsolete?

Watch the full debate to hear two leading experts tackle one of the most talked-about questions in obesity care. In this episode, Prof. Francesco Rubino (King’s College London) and Dr. Louis Aronne (Cornell Medical College) join Vivienne Parry to debate whether next-generation medications will eventually make obesity surgery obsolete.

The conversation covers: •The evolving role of bariatric surgery in an era of powerful GLP-1-based therapies •What new medications and minimally invasive procedures could reshape obesity care •The economic, clinical, and patient-preference factors influencing treatment choices •Why obesity management is moving toward multi-modal, integrated care models •The importance of tackling stigma and ensuring equitable access to treatment

For deeper insights into incretin science, clinical outcomes, and next-generation therapies, learn more about our expert speakers:

1. Francesco Rubino
2. Louis Aronne